Zhejiang CONBA Pharmaceutical Co Ltd (600572)

Currency in CNY
4.57
+0.01(+0.22%)
Closed·
600572 Scorecard
Full Analysis
Management has been aggressively buying back shares
600572 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.514.59
52 wk Range
3.915.41
Key Statistics
Bid/Ask
4.57 / 4.58
Prev. Close
4.56
Open
4.57
Day's Range
4.51-4.59
52 wk Range
3.91-5.41
Volume
25.28M
Average Volume (3m)
25.86M
1-Year Change
6.78%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600572 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Zhejiang CONBA Pharmaceutical Co Ltd Company Profile

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it offers prescription pieces, formula granules, plant extracts, and other products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.

Employees
8411
Market
China

Compare 600572 to Peers and Sector

Metrics to compare
600572
Peers
Sector
Relationship
P/E Ratio
18.9x33.1x−0.5x
PEG Ratio
1.40−1.030.00
Price/Book
1.6x3.0x2.6x
Price / LTM Sales
1.8x4.2x3.2x
Upside (Analyst Target)
-7.2%44.6%
Fair Value Upside
Unlock5.3%6.5%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.24%
Dividend Yield
3.28%
Industry Median 1.53%
Annualised payout
0.15
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 05, 2025
EPS / Forecast
0.06 / --
Revenue / Forecast
1.68B / --
EPS Revisions
Last 90 days

600572 Income Statement

FAQ

What Stock Exchange Does Zhejiang CONBA Pharm Trade On?

Zhejiang CONBA Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang CONBA Pharm?

The stock symbol for Zhejiang CONBA Pharm is "600572."

What Is the Zhejiang CONBA Pharm Market Cap?

As of today, Zhejiang CONBA Pharm market cap is 11.23B.

What Is Zhejiang CONBA Pharm's Earnings Per Share (TTM)?

The Zhejiang CONBA Pharm EPS (TTM) is 0.24.

When Is the Next Zhejiang CONBA Pharm Earnings Date?

Zhejiang CONBA Pharm will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is 600572 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Zhejiang CONBA Pharm Stock Split?

Zhejiang CONBA Pharm has split 4 times.

How Many Employees Does Zhejiang CONBA Pharm Have?

Zhejiang CONBA Pharm has 8411 employees.

What is the current trading status of Zhejiang CONBA Pharm (600572)?

As of 19 Jul 2025, Zhejiang CONBA Pharm (600572) is trading at a price of 4.57, with a previous close of 4.56. The stock has fluctuated within a day range of 4.51 to 4.59, while its 52-week range spans from 3.91 to 5.41.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.